BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Asieris Pharma Closes $15M B Round Financing

  The company will use the capital to support a China Phase III trial of APL-1202, a repurposed oral inhibitor of MetAP2.

  December 28, 2017

   · 

  1 min read
• 

  Business

  Merck Serono, WuXi AppTec and Pontifax Form Israeli Life Science Incubator

  The incubator will be located at Merck Serono’s current facilities in Yavne, a town in central Israel.

  December 28, 2017

   · 

  1 min read
• 

  Job Trends

  Germany’s Vetter Begins Construction on $350M 500-Job U.S. HQ

  The entire 1.2 million-square-feet facility is expected to be finished in 2030.

  December 28, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  China Approves Becton Dickinson-C.R. Bard Merger

  “MOFCOM clearance was the final regulatory approval needed to complete the Bard acquisition,” said Vincent A. Forlenza, chairman and CEO of BD.

  December 28, 2017

   · 

  2 min read
• Critical Outcome Technologies Awards Stock Options

  Critical Outcome Technologies announced today that 346,428 stock options were awarded to directors under the Company’s Stock Option Plan on December 20, 2017.

  December 28, 2017

   · 

  2 min read
• Pharm Country

  PAVmed Announces Temporary Offer Allowing Warrants to Be Exercised at a Reduced Price

  The Company intends to file tender offer materials providing the holders of certain warrants the opportunity to exercise their warrants at the temporarily reduced cash exercise price.

  December 28, 2017

   · 

  5 min read
• Business

  Stem Cell Leaders Join Frequency Therapeutics’ PCA Regenerative Medicine Scientific Advisory Board

  As our lead program for hearing regeneration advances on schedule, we are pleased to formally acknowledge the input from the world’s leading stem cell and regenerative medicine experts who are guiding both our hearing program and additional therapeutic opportunities for our PCA Regeneration platform.

  December 28, 2017

   · 

  8 min read
• Business

  Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2017 Financial Results

  Zoetis (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Feb. 15, 2018.

  December 28, 2017

   · 

  1 min read
• Genetown

  Cellular Biomedicine Group Announces Closing of $14.5M Private Placement Offering

  The Company intends to use the proceeds from the financings to fund clinical trials and more.

  December 28, 2017

   · 

  4 min read
• Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018

  Following the announcement, Auris Medical’s management team will host a live conference call and webcast at 8:00 AM ET.

  December 28, 2017

   · 

  1 min read